Compare TREE & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TREE | XOMA |
|---|---|---|
| Founded | 1996 | 1981 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 541.5M | 471.6M |
| IPO Year | 2008 | N/A |
| Metric | TREE | XOMA |
|---|---|---|
| Price | $38.78 | $41.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $71.25 | $52.50 |
| AVG Volume (30 Days) | ★ 174.5K | 91.2K |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 443.31 | N/A |
| EPS | ★ 1.22 | N/A |
| Revenue | ★ $1,117,324,000.00 | N/A |
| Revenue This Year | $19.03 | $24.59 |
| Revenue Next Year | $7.07 | N/A |
| P/E Ratio | $32.12 | ★ $29.64 |
| Revenue Growth | ★ 24.12 | N/A |
| 52 Week Low | $32.65 | $22.29 |
| 52 Week High | $77.35 | $42.81 |
| Indicator | TREE | XOMA |
|---|---|---|
| Relative Strength Index (RSI) | 53.94 | 59.80 |
| Support Level | $39.05 | $37.00 |
| Resistance Level | $40.00 | $42.25 |
| Average True Range (ATR) | 1.82 | 0.36 |
| MACD | 0.39 | -0.16 |
| Stochastic Oscillator | 81.37 | 48.48 |
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.